Kevin A. Serpa

760 total citations
19 papers, 616 citations indexed

About

Kevin A. Serpa is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Kevin A. Serpa has authored 19 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cellular and Molecular Neuroscience, 10 papers in Molecular Biology and 6 papers in Organic Chemistry. Recurrent topics in Kevin A. Serpa's work include Neuroscience and Neuropharmacology Research (14 papers), Receptor Mechanisms and Signaling (6 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). Kevin A. Serpa is often cited by papers focused on Neuroscience and Neuropharmacology Research (14 papers), Receptor Mechanisms and Signaling (6 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). Kevin A. Serpa collaborates with scholars based in United States, France and United Kingdom. Kevin A. Serpa's co-authors include Leonard T. Meltzer, Curt Christoffersen, Lawrence D. Wise, Edward R. Whittemore, Richard M. Woodward, Christopher S. Konkoy, Tracy F. Gregory, Peter A. Boxer, Thomas A. Pugsley and Charles P. Taylor and has published in prestigious journals such as Brain Research, Neuroscience & Biobehavioral Reviews and Journal of Medicinal Chemistry.

In The Last Decade

Kevin A. Serpa

19 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin A. Serpa United States 13 301 240 192 105 67 19 616
S.M. Sorensen United States 10 485 1.6× 258 1.1× 99 0.5× 117 1.1× 114 1.7× 15 676
Steven Z. Whetzel United States 13 443 1.5× 433 1.8× 227 1.2× 93 0.9× 29 0.4× 20 841
A. Bonsignori Italy 8 272 0.9× 206 0.9× 131 0.7× 113 1.1× 41 0.6× 19 585
Stephen M. Sorensen United States 14 487 1.6× 278 1.2× 176 0.9× 131 1.2× 81 1.2× 19 816
Robert Neale Switzerland 14 348 1.2× 242 1.0× 72 0.4× 147 1.4× 35 0.5× 25 599
P. Granger United States 10 320 1.1× 201 0.8× 48 0.3× 78 0.7× 134 2.0× 17 492
George A. Stone Switzerland 13 341 1.1× 436 1.8× 182 0.9× 107 1.0× 26 0.4× 16 815
Antony R. Knight United Kingdom 9 385 1.3× 337 1.4× 113 0.6× 60 0.6× 58 0.9× 10 595
Margaret M. Schweri United States 21 669 2.2× 428 1.8× 213 1.1× 164 1.6× 98 1.5× 31 958
Haruhiko Shinozaki Japan 12 469 1.6× 421 1.8× 152 0.8× 37 0.4× 66 1.0× 45 686

Countries citing papers authored by Kevin A. Serpa

Since Specialization
Citations

This map shows the geographic impact of Kevin A. Serpa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin A. Serpa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin A. Serpa more than expected).

Fields of papers citing papers by Kevin A. Serpa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin A. Serpa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin A. Serpa. The network helps show where Kevin A. Serpa may publish in the future.

Co-authorship network of co-authors of Kevin A. Serpa

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin A. Serpa. A scholar is included among the top collaborators of Kevin A. Serpa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin A. Serpa. Kevin A. Serpa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Johnson, Douglas S., Chung Sik Choi, David A. Favor, et al.. (2011). Discovery of PF-00217830: Aryl piperazine napthyridinones as D2 partial agonists for schizophrenia and bipolar disorder. Bioorganic & Medicinal Chemistry Letters. 21(9). 2621–2625. 19 indexed citations
2.
Favor, David A., et al.. (2010). 6-Alkoxyisoindolin-1-one based dopamine D2 partial agonists as potential antipsychotics. Bioorganic & Medicinal Chemistry Letters. 20(19). 5666–5669. 8 indexed citations
3.
Marston, Hugh, Jared W. Young, Kevin A. Serpa, et al.. (2009). Asenapine effects in animal models of psychosis and cognitive function. Psychopharmacology. 206(4). 699–714. 42 indexed citations
4.
Vartanian, Mark G., Louis L. Radulovic, Jack J. Kinsora, et al.. (2005). Activity profile of pregabalin in rodent models of epilepsy and ataxia. Epilepsy Research. 68(3). 189–205. 82 indexed citations
5.
Nikam, Sham S., Jon L. Wright, Suzanne R. Kesten, et al.. (2004). Subtype selective NMDA receptor antagonists: evaluation of some novel alkynyl analogues. Bioorganic & Medicinal Chemistry Letters. 14(5). 1213–1216. 7 indexed citations
6.
Böhme, Thomas, Corinne E. Augelli‐Szafran, Hussein Hallak, et al.. (2002). Synthesis and Pharmacology of Benzoxazines as Highly Selective Antagonists at M4Muscarinic Receptors. Journal of Medicinal Chemistry. 45(14). 3094–3102. 67 indexed citations
7.
Wright, Jonathan L., Tracy F. Gregory, Suzanne R. Kesten, et al.. (2000). Subtype-Selective N-Methyl-d-Aspartate Receptor Antagonists:  Synthesis and Biological Evaluation of 1-(Heteroarylalkynyl)-4-benzylpiperidines. Journal of Medicinal Chemistry. 43(18). 3408–3419. 95 indexed citations
8.
Gregory, Tracy F., Jon L. Wright, Lawrence D. Wise, et al.. (2000). Parallel synthesis of a series of subtype-selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 10(6). 527–529. 8 indexed citations
9.
Yuen, Po‐wai, Kevin A. Serpa, Leonard T. Meltzer, et al.. (2000). ChemInform Abstract: Subtype‐Selective N‐Methyl‐D‐aspartate Receptor Antagonists: Benzimidazolone and Hydantoin as Phenol Replacements.. ChemInform. 31(31). 3 indexed citations
10.
Wright, Jon L., Tracy F. Gregory, Christopher F. Bigge, et al.. (1999). Subtype-Selective N-Methyl-d-aspartate Receptor Antagonists:  Synthesis and Biological Evaluation of 1-(Arylalkynyl)-4-benzylpiperidines. Journal of Medicinal Chemistry. 42(13). 2469–2477. 85 indexed citations
11.
Wright, Jon L., Tracy F. Gregory, Peter A. Boxer, et al.. (1999). Discovery of subtype-selective NMDA receptor ligands: 4-Benzyl-1-piperidinylalkynylpyrroles, pyrazoles and imidazoles as NR1a/2B antagonists. Bioorganic & Medicinal Chemistry Letters. 9(19). 2815–2818. 15 indexed citations
12.
Meltzer, Leonard T., Curt Christoffersen, & Kevin A. Serpa. (1997). Modulation of dopamine neuronal activity by glutamate receptor subtypes. Neuroscience & Biobehavioral Reviews. 21(4). 511–518. 76 indexed citations
13.
Meltzer, Leonard T., Curt Christoffersen, A. Corbin, et al.. (1995). CI-1007, a dopamine partial agonist and potential antipsychotic agent. II. Neurophysiological and behavioral effects.. Journal of Pharmacology and Experimental Therapeutics. 274(2). 912–920. 11 indexed citations
14.
Meltzer, Leonard T., Bradley W. Caprathe, Curt Christoffersen, et al.. (1993). Pharmacological profile of the dopamine partial agonist, (+/-)-PD 128483 and its enantiomers.. Journal of Pharmacology and Experimental Therapeutics. 266(3). 1177–1189. 2 indexed citations
15.
Meltzer, Leonard T., Curt Christoffersen, Kevin A. Serpa, et al.. (1992). Lack of involvement of haloperidol-sensitive sigma binding sites in modulation of dopamine neuronal activity and induction of dystonias by antipsychotic drugs. Neuropharmacology. 31(9). 961–967. 13 indexed citations
16.
Meltzer, Leonard T., Kevin A. Serpa, & Walter H. Moos. (1989). Evaluation in rats of the somnogenic, pyrogenic, and central nervous system depressant effects of muramyl dipeptide. Psychopharmacology. 99(1). 103–108. 34 indexed citations
17.
Meltzer, Leonard T. & Kevin A. Serpa. (1988). Assessment of hypnotic effects in the rat: Influence of the sleep‐awake cycle. Drug Development Research. 14(2). 151–159. 14 indexed citations
18.
Burchfiel, James L., Kevin A. Serpa, & Frank H. Duffy. (1982). Further studies of antagonism of seizure development between concurrently developing kindled limbic foci in the rat. Experimental Neurology. 75(2). 476–489. 18 indexed citations
19.
Burchfiel, James L., Kevin A. Serpa, & Frank H. Duffy. (1982). Kindling antagonism: Interactions of dorsal and ventral entorhinal cortex with the septum during concurrent kindling. Brain Research. 238(1). 3–12. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S.M. Sorensen Breakdown of academic impact, for papers by Steven Z. Whetzel Breakdown of academic impact, for papers by A. Bonsignori Breakdown of academic impact, for papers by Stephen M. Sorensen Breakdown of academic impact, for papers by Robert Neale Breakdown of academic impact, for papers by P. Granger Breakdown of academic impact, for papers by George A. Stone Breakdown of academic impact, for papers by Antony R. Knight Breakdown of academic impact, for papers by Margaret M. Schweri Breakdown of academic impact, for papers by Haruhiko Shinozaki
Rankless by CCL
2026